This is a program of the U.S. Department of Health and Human Services, Office of Public Health Emergency Medical Countermeasures, and the National Institutes of Health. The program is coordinated by NIAID, with the involvement of the National Cancer Institute.
BAA-NIAID-DAIT-NIHAI2015042: Development of Radiation/Nuclear Medical Countermeasures or Biodosimetry Devices. Response date – March 22, 2016
RFA-HL-16-003: Collaborative Projects to Accelerate Research in Organ Fibrosis (R01) (co-funded by NIAID)—Receipt date Oct. 21, 2016
Pre-Solicitation Notice: BAA-NIAID-DAIT-NIHAI2015042: Development of Radiation/Nuclear Medical Countermeasures or Biodosimetry Devices—Posted Dec. 8, 2015
Pegfilgrastim Approved for Treatment of Acute Radiation Syndrome—Dec. 3, 2015
NCATS’ Pre-Clinical Programs Now Accepting Collaborative Proposals—Posted October 2015
RFA-AG-16-020: Impact of Aging on Currently Employed Animal Models of Disease and Chronic Conditions: Demonstration Projects (UH2/UH3) (co-funded by NIAID)—Receipt date Jan. 6, 2016.
All Radiological and Nuclear Threats News Releases
News From NIAID-Supported Institutions
Last Updated December 29, 2015